Mylotarg and malignant neoplasm progression 
Mylotarg and malignant neoplasm progression Patient Reports February 12, 2012
Mylotarg Side Effects Report #5102975-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 29, 2006. Female patient, 84 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, confusional state, malignant neoplasm progression, neutrophil count decreased, sepsis
. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with DIFLUCAN, PROTECADIN, MUCOSTA, VIT K CAP, SULFAMETHOXAZOLE, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5084004-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 02, 2006. Female patient, 78 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, febrile neutropenia, malignant neoplasm progression, pneumonia
, sepsis . Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, URSO, OMEPRAZOLE, SULFAMETHOXAZOLE, DIFLUCAN, STRONG NEO MINOPHAGEN C. Patient died.Mylotarg Side Effects Report #5110505-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Sept 04, 2006. Male patient, 68 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disseminated intravascular coagulation, fatigue, febrile neutropenia, hypotension, malignant neoplasm progression, pneumonia
, pyrexia, thrombocytopenia. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with ITRACONAZOLE, SULFAMETHOXAZOLE, NEORAL, TENORMIN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4943875-X
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Feb 28, 2006. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood calcium decreased, blood creatinine increased, blood potassium decreased, blood urea increased, haemorrhagic diathesis, malignant neoplasm progression, neutrophil percentage decreased, platelet count decreased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, DIFLUCAN, CLARITHROMYCIN, FAMOTIDINE, MUCOSTA. Patient died.
Mylotarg Side Effects Report #5197491-8
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 20, 2006. Female patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blast cell count decreased, blood lactate dehydrogenase increased, blood urea decreased, fibrin degradation products increased, haematocrit decreased, haemoglobin decreased, malignant neoplasm progression, myeloid leukaemia, neutrophil count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with FIRSTCIN, TIENAM, OMEGACIN, FUNGUARD, PRODIF, FARESTON, RISPERDAL. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #4979710-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 06, 2006. Female patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, blood lactate dehydrogenase increased, cellulitis
, chills, malignant neoplasm progression, platelet count decreased, pyrexia. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with ANASTROZOLE, FAMOTIDINE, LEVOFLOXACIN, BIOFERMIN R, SULFAMETHOXAZOLE, FLUCONAZOLE. Patient recovered.Mylotarg Side Effects Report #5196095-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 13, 2006. Female patient, 47 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, disease recurrence, lung injury, malignant neoplasm progression, mouth haemorrhage, platelet count decreased, po2 decreased, pseudomonal sepsis. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with DAUNORUBICIN HYDROCHLORIDE, HYDREA, SULPERAZON, TOBRAMYCIN SULPHATE, FUNGUARD, ZOVIRAX, URSO. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4974412-1
Mylotarg side effect was reported by a Health Professional from JAPAN on Mar 29, 2006. Female patient, 44 years of age, was diagnosed with acute myeloid leukaemia recurrent, bone marrow conditioning regimen and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, febrile neutropenia, fibrin degradation products increased, hyperkalaemia, hyponatraemia, interstitial lung disease, malignant neoplasm progression, proctalgia, venoocclusive liver disease. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE. During the same period patient was treated with LAMIVUDINE, SULFAMETHOXAZOLE, DIFLUCAN, BUSULFAN, CIPROFLOXACIN HYDROCHLORIDE, ZOLPIDEM TARTRATE, MAXIPIME. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #4930068-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Feb 16, 2006. Female patient, 43 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, agranulocytosis, anaemia, blood alkaline phosphatase increased, blood bilirubin increased, liver disorder, lymphocyte percentage increased, malignant neoplasm progression, monocyte percentage decreased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with CYTARABINE, BESTATIN, MEROPEN, VANCOMYCIN HYDROCHLORIDE, PRODIF, ZOVIRAX. Patient recovered.
Mylotarg Side Effects Report #4953986-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 10, 2006. Female patient, 43 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, agranulocytosis, anaemia, blood alkaline phosphatase increased, blood bilirubin increased, body temperature increased, lymphocyte percentage increased, malignant neoplasm progression, monocyte percentage increased. Mylotarg dosage: A SINGLE 9 MG/M2 DOSE. During the same period patient was treated with CYTARABINE, BESTATIN, MEROPEN, VANCOMYCIN HYDROCHLORIDE, PRODIF, ZOVIRAX. Patient recovered.
Mylotarg Side Effects Report #4995945-8
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 21, 2006. Female patient, 43 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, agranulocytosis, anaemia, blood alkaline phosphatase increased, blood bilirubin increased, body temperature increased, malignant neoplasm progression, monocyte percentage decreased, neutrophil percentage decreased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with BESTATIN, MEROPEN, VANCOMYCIN HYDROCHLORIDE, PRODIF, ZOVIRAX. Patient recovered.
Mylotarg Side Effects Report #5583086-0
Mylotarg side effect was reported by a Physician from JAPAN on Dec 26, 2007. Female patient, weighting 108.0 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, c-reactive protein increased, fungaemia, hepatic function abnormal, infusion related reaction, malignant neoplasm progression, neutropenia, platelet count decreased, sepsis
. Mylotarg dosage: unknown. During the same period patient was treated with DIFLUCAN, BAKTAR, GASTER. Patient recovered.Mylotarg Side Effects Report #4973907-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 28, 2006. Male patient, 87 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression. Mylotarg dosage: A SINGLE 13.3 MG DOSE, INTRAVENOUS. Patient died on 03/26/2006.
Mylotarg Side Effects Report #5069585-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on July 20, 2006. Male patient, 84 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blast cell count increased, epistaxis, hiccups, malignant neoplasm progression, platelet count decreased, pyrexia. Mylotarg dosage: unknown. During the same period patient was treated with FAMOTIDINE, DIFLUCAN, ROHYPNOL, LENDORM, DEPAS, CIPROXAN. Patient recovered.
Mylotarg Side Effects Report #4867664-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 03, 1999. Female patient, 80 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression, nausea
, neutropenia, pyrexia. Mylotarg dosage: 9 MG/M (2), INTRAVENOUS. Patient was hospitalized. Patient died on 12/22/1998.Mylotarg Side Effects Report #4952638-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 01, 2004. Male patient, 79 years of age, weighting 187.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, bacteria blood identified, chills, febrile neutropenia, infusion related reaction, malignant neoplasm progression, pneumonia
, pyrexia, white blood cell count abnormal. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS. During the same period patient was treated with HYDREA, SYNTHROID, PREVACID, ALLOPURINOL. Patient was hospitalized. Patient died on 01/22/2003.Mylotarg Side Effects Report #5042462-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on June 14, 2006. Female patient, 79 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blast cell count increased, blood lactate dehydrogenase increased, c-reactive protein increased, malignant neoplasm progression, pyrexia. Mylotarg dosage: A SINGLE 7.1 MG/M^2 DOSE, INTRAVENOUS DRIP. During the same period patient was treated with ZANTAC, LENDORM, DIFLUCAN, SOLON, MAGNESIUM OXIDE, ZOLPIDEM TARTRATE, FIRSTCIN, CEFPIRAMIDE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4943877-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 01, 2006. Female patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood pressure diastolic decreased, body temperature decreased, fall
, haematocrit decreased, haemoglobin decreased, head injury, malignant neoplasm progression, neutrophil count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with AMLODIPINE BESYLATE, BEPRIDIL HYDROCHLORIDE MONOHYDRATE, DIOVAN. Patient died.Mylotarg Side Effects Report #4899279-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 20, 2006. Male patient, 74 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood potassium decreased, febrile neutropenia, hypoxia, malignant neoplasm progression, ventricular tachycardia. Mylotarg dosage: 9 MG/M^2 1X PER DAY, INTRAVENOUS DRIP. During the same period patient was treated with ACLARUBICIN HYDROCHLORIDE, CYTARABINE. Patient died.
Mylotarg Side Effects Report #4867537-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 14, 2005. Female patient, 73 years of age, weighting 140.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, febrile neutropenia, malignant neoplasm progression, platelet count decreased. Mylotarg dosage: 1 SINGLE 9 MG DOSE, INTRAVENOUS; SEE IMAGE. Patient was hospitalized. Patient died on 09/05/2005.
Mylotarg Side Effects Report #5042162-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 12, 2006. Male patient, 72 years of age, weighting 173.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: cardiac failure congestive, chills, headache
, hypoaesthesia, lung infiltration, malignant neoplasm progression, nausea , pulmonary oedema, pyrexia. Mylotarg dosage: unknown. During the same period patient was treated with CIPRO. Patient died on 03/18/2005.Mylotarg Side Effects Report #5090633-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2006. Female patient, 70 years of age, weighting 140.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, bacterial sepsis, blood culture positive, dyspnoea, febrile neutropenia, hypotension, malignant neoplasm progression, staphylococcal infection
, thrombocytopenia. Mylotarg dosage: 16 MG IV EVERY 14 DAYS, INTRAVENOUS. During the same period patient was treated with GLUCOTROL, IMMUNE SERUM GLOBULIN. Patient was hospitalized. Patient died on 04/12/2003.Mylotarg Side Effects Report #4899281-X
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 18, 2006. Female patient, 70 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood creatinine increased, blood urea increased, febrile neutropenia, fibrin degradation products increased, immunosuppression, interstitial lung disease, malignant neoplasm progression, pneumonia fungal. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with OZEX, ITRACONAZOLE, SULFAMETHOXAZOLE, URSO, ACTOS. Patient died.
Mylotarg Side Effects Report #4867658-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2002. Female patient, 69 years of age, weighting 145.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, atrial fibrillation
, febrile neutropenia, furuncle, hypotension, malignant neoplasm progression, sepsis . Mylotarg dosage: 9 MG/M^2 1X PER 1 DOS, INTRAVENOUS. During the same period patient was treated with LEVOTHYROXINE, DIGOXIN, OMEPRAZOLE, ALLOPURINOL. Patient was hospitalized. Patient died on 11/11/1999.Mylotarg Side Effects Report #4959814-1
Mylotarg side effect was reported by a Health Professional from JAPAN on Mar 20, 2006. Female patient, 69 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, haematocrit decreased, haemoglobin decreased, malignant neoplasm progression, platelet count decreased, red blood cell count decreased, sepsis
. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with FAMOTIDINE, PANTOSIN, MAGNESIUM OXIDE, LASIX, KYTRIL, LOXONIN, MUCOSTA. Patient recovered.Mylotarg Side Effects Report #4754314-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 19, 2005. Female patient, 67 years of age, weighting 117.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, dyspnoea, hepatotoxicity, malignant neoplasm progression, pleural effusion. Mylotarg dosage: 9.1 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 04/03/2004.
Mylotarg Side Effects Report #4942641-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 24, 2006. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, cellulitis
, malignant neoplasm progression. Mylotarg dosage: unknown. Patient was hospitalized. Patient died on 12/17/2005.Mylotarg Side Effects Report #5142837-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 23, 2006. Female patient, 66 years of age, weighting 106.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, culture urine positive, enterococcal infection, haemoptysis, hydropneumothorax, leukaemia cutis, malignant neoplasm progression, pharyngolaryngeal pain. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 12/03/2003.
Mylotarg Side Effects Report #4953648-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 64 years of age, weighting 164.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, chills, dyspnoea, hypotension, infusion related reaction, malignant neoplasm progression, oxygen saturation decreased, pyrexia, tachycardia. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, DIPHENHYDRAMINE, PERCOCET, RESTORIL, ATIVAN. Patient died on 07/31/2003.
Mylotarg Side Effects Report #5042480-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on June 12, 2006. Male patient, 64 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, febrile neutropenia, histiocytosis haematophagic, malignant neoplasm progression, pulmonary haemorrhage. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with NEUQUINON, METHYCOBAL. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #4709010-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 10, 2004. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, asthenia, fatigue, malignant neoplasm progression, multi-organ failure, pain
, pleural effusion, pyrexia. Mylotarg dosage: 2 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, DIPHENHYDRAMINE, MDIAZOLAM, FENTANYL, HYDROCORTISONE NA SUCCINATE, CYCLOSPORINE. Patient was hospitalized. Patient died on 09/17/2002.Mylotarg Side Effects Report #4977726-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 03, 2006. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute monocytic leukaemia, c-reactive protein increased, infection
, malignant neoplasm progression, neutrophil count decreased, platelet count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with LEVOFLOXACIN, DIFLUCAN, SULPERAZONE. Patient recovered.Mylotarg Side Effects Report #5007452-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 09, 2006. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, infection
, malignant neoplasm progression, neutrophil count decreased, platelet count decreased, pyrexia. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with LEVOFLOXACIN, DIFLUCAN. Patient recovered.Mylotarg Side Effects Report #4867706-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 09, 1999. Male patient, 61 years of age, weighting 179.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, lung infiltration, malignant neoplasm progression, mental status changes, neutropenia, pyrexia. Mylotarg dosage: 9 MG/M(2), INTRAVENOUS. Patient was hospitalized. Patient died on 12/08/1999.
Mylotarg Side Effects Report #4914311-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 08, 2002. Male patient, 61 years of age, weighting 179.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, lung infiltration, malignant neoplasm progression, mental status changes, neutropenia, pyrexia. Mylotarg dosage: 9 MG/M(2), INTRAVENOUS. Patient was hospitalized. Patient died on 12/08/1999.
Mylotarg Side Effects Report #5053180-1
Mylotarg side effect was reported by a Health Professional from UNITED STATES on June 29, 2006. Male patient, 60 years of age, weighting 261.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, bacteria stool identified, diarrhoea, febrile neutropenia, haemoglobin decreased, hyponatraemia, malignant neoplasm progression, nausea
, renal failure. Mylotarg dosage: INTRAVENOUS, 18MG 1X PER 1 DAY; INTRAVENOUS. During the same period patient was treated with PROTONIX, ZOLOFT, COMBIVENT, COREG, NEURONTIN, LEVAQUIN, LASIX. Patient was hospitalized. Patient died on 03/05/2004.Mylotarg Side Effects Report #4685924-2
Mylotarg side effect was reported by a Physician from on May 25, 2005. Female patient, 59 years of age, weighting 101.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, febrile neutropenia, malignant neoplasm progression, pancytopenia, streptococcal infection
. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ASPIRIN, LANOXIN, ENALAPRIL MALEATE, ACYCLOVIR, PROZAC, DEMECLOCYCLINE, DIFLUCAN. Patient was hospitalized. Patient died on 04/22/2003.Mylotarg Side Effects Report #5113466-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Sept 08, 2006. Male patient, 58 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood lactate dehydrogenase increased, cardiac failure congestive, condition aggravated, haemoglobin decreased, interstitial lung disease, malignant neoplasm progression, performance status decreased, red blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with ITRACONAZOLE, CIPROXAN, ALLOPURINOL, DIOVAN, LANSOPRAZOLE, SELBEX, MAGNESIUM OXIDE, DEXTROMETHORPHAN HYDROBROMIDE. Patient recovered.
Mylotarg Side Effects Report #4744989-X
Mylotarg side effect was reported by a Physician from UNITED STATES on Aug 03, 2005. Male patient, 58 years of age, weighting 212.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, aspartate aminotransferase increased, beta haemolytic streptococcal infection, blood alkaline phosphatase increased, blood bilirubin increased, blood culture positive, malignant neoplasm progression, oedema peripheral, sepsis
. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with AVANDIA, SPORANOX, CIPRO, KEFLEX, VALCYTE, FOLIC ACID, DIGOXIN. Patient was hospitalized. Patient died on 09/07/2003.Mylotarg Side Effects Report #5053178-3
Mylotarg side effect was reported by a Health Professional from UNITED STATES on June 29, 2006. Female patient, 55 years of age, weighting 194.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, malignant neoplasm progression, weight increased. Mylotarg dosage: 14.85 MG 1X PER 1 DAY; INTRAVENOUS. Patient died on 01/07/2006.
Mylotarg Side Effects Report #5079822-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 26, 2006. Female patient, 49 years of age, weighting 123.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression, sepsis
. Mylotarg dosage: 9 MG, INTRAVENOUS. Patient was hospitalized. Patient died on 05/09/2002.Mylotarg Side Effects Report #5141862-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Oct 20, 2006. Male patient, 48 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, hypercoagulation, hypoalbuminaemia, hypokalaemia, hypoproteinaemia, malignant neoplasm progression, neutropenia, pneumonia
. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with FIRSTCIN, FUTHAN, DIFLUCAN, TIENAM, AMIKACIN SULPHATE. Patient died.Mylotarg Side Effects Report #4971950-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 28, 2006. Male patient, 47 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, fibrin degradation products increased, fungal infection
, haemoglobin decreased, immunodeficiency, malignant neoplasm progression, platelet count decreased, sepsis , weight increased. Mylotarg dosage: unknown. During the same period patient was treated with POLYMYXIN B SULPHATE, DIFLUCAN, SULFAMETHOXAZOLE, MUCOSTA. Patient recovered.Mylotarg Side Effects Report #5013787-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on May 17, 2006. Male patient, 37 years of age, weighting 271.8 lb, was diagnosed with acute myeloid leukaemia, fungal infection
and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, febrile neutropenia, malignant neoplasm progression, renal failure, white blood cell count decreased. Mylotarg dosage: 9 MG/M^1 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with AMPHOTERICIN B, DEMEROL, AMILORIDE, ASCORBIC ACID, VITAMINS, NEURONTIN, BENADRYL. Patient was hospitalized. Patient died on 01/29/2003.Mylotarg Side Effects Report #5085875-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 08, 2006. Female patient, 36 years of age, weighting 231.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain
, acute myeloid leukaemia, hepatic failure, malignant neoplasm progression, multi-organ failure, renal failure, respiratory failure. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with HALDOL, ATIVAN, ACYCLOVIR, COMBIVENT. Patient was hospitalized. Patient died on 10/14/2003.Mylotarg Side Effects Report #5135805-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2006. Female patient, 36 years of age, weighting 231.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain
, acute myeloid leukaemia, hepatic failure, malignant neoplasm progression, multi-organ failure, pulmonary alveolar haemorrhage, renal failure, respiratory failure. Mylotarg dosage: unknown. During the same period patient was treated with HALDOL, ATIVAN, ACYCLOVIR, COMBIVENT. Patient was hospitalized. Patient died on 10/14/2003.Mylotarg Side Effects Report #4893553-0
Mylotarg side effect was reported by a Health Professional from JAPAN on Jan 10, 2006. Male patient, 31 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, infusion related reaction, malignant neoplasm progression, sepsis
. Mylotarg dosage: A SINGLE 15 MG DOSE. During the same period patient was treated with ETOPOSIDE, OMEPRAZOLE, DIFLUCAN, CLOSTRIDIUM BUTYRICUM, CYTARABINE, MINOPEN, HABEKACIN, GRAN. Patient died.Mylotarg Side Effects Report #4976448-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 03, 2006. Male patient, 31 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood potassium decreased, blood sodium decreased, condition aggravated, infusion related reaction, leukaemia recurrent, malignant neoplasm progression, staphylococcal sepsis. Mylotarg dosage: A SINGLE 15 MG DOSE (9 MG/M^2). During the same period patient was treated with CYTARABINE, ETOPOSIDE, OMEPRAZOLE, DIFLUCAN, CLOSTRIDIUM BUTYRICUM, MINOPEN, HABEKACIN, NEUPOGEN. Patient died.
Mylotarg Side Effects Report #5097615-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 22, 2006. Male patient, 30 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, blood creatinine increased, blood potassium increased, blood urea increased, cystitis haemorrhagic, malignant neoplasm progression, mouth haemorrhage, platelet count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with DIFLUCAN, AMLODIPINE BESYLATE, FAMOTIDINE, SULFAMETHOXAZOLE, PREDNISOLONE, LOSARTAN POTASSIUM, LASIX. Patient died.
Mylotarg Side Effects Report #4655982-X
Mylotarg side effect was reported by a Health Professional from on May 06, 2005. Male patient, 15 years of age, weighting 112.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, acute respiratory distress syndrome, arrhythmia
, blood pressure decreased, bone marrow disorder, central line infection, dyspnoea, malignant neoplasm progression, malignant pleural effusion. Mylotarg dosage: 12.5 MG, 1 DOSE, INFUSION LINE. During the same period patient was treated with CYTARABINE, IMMUNE GLOBULIN, LIPOSOMAL AMPHOTERICIN, VORICONAZOLE. Patient died on 04/11/2005.